Does HERV-K represent a potential therapeutic target for prostate cancer?
- 30 August 2017
- journal article
- editorial
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 21 (10) , 921-924
Abstract
Only a few years ago, a new virus was proposed as a possible cause of human prostate cancer. After extensive debate and thorough forensic tracking, XMRV (Xenotropic murine leukemia virus-related vi...Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Schu604-16/3)
- Reinhard-Nagel-Stiftung (Suppl. funding to Schu604-16/3)
This publication has 18 references indexed in Scilit:
- Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model systemVirology Journal, 2014
- Endogenous Retroviruses and Human Cancer: Is There Anything to the Rumors?Cell Host & Microbe, 2014
- Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG ProteinClinical Cancer Research, 2013
- Transcriptional Profiling of Human Endogenous Retrovirus Group HERV-K(HML-2) Loci in MelanomaGenome Biology and Evolution, 2013
- Human endogenous retroviruses and cancer prevention: evidence and prospectsBMC Cancer, 2013
- Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell LinesFrontiers in Oncology, 2013
- Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and ImmunogenicThe Journal of Immunology, 2012
- Selective changes of retroelement expression in human prostate cancerCarcinogenesis, 2011
- Human endogenous retrovirus protein Rec interacts with the testicular zinc-finger protein and androgen receptorJournal of General Virology, 2010
- Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome ProjectBMC Genomics, 2008